Draft guidance issued for consultation recommends the use of 4 AI technologies to help professionals detect fractures in ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

Studies have showed using TriageHF reduced all-cause hospitalisations by 58% according to Ahmed et al. (2024). Using ...

Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...

The updated guideline recommends offering a comprehensive falls assessment and management for people who have fallen in the ...

There is a simple discount patient access scheme for danicopan. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

This guidance replaces NICE medtech innovation briefing 298 on TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart ...

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this ...

There is a simple discount patient access scheme for quizartinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact pasinfo@daiichi ...

The diagnostics advisory committee looked at evidence on algorithm-based remote monitoring of heart failure in people with cardiac implantable electronic devices (CIEDs). Evidence was considered from ...